Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:urofollitropin
|
| gptkbp:administeredBy |
injection
|
| gptkbp:ATCCode |
gptkb:G03GA04
|
| gptkbp:contains |
follicle stimulating hormone
|
| gptkbp:contraindication |
primary ovarian failure
ovarian enlargement uncontrolled thyroid or adrenal dysfunction |
| https://www.w3.org/2000/01/rdf-schema#label |
Fostimon
|
| gptkbp:indication |
ovarian stimulation
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:IBSA_Institut_Biochimique_SA
|
| gptkbp:pregnancyCategory |
not for use in pregnancy
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
subcutaneous
|
| gptkbp:sideEffect |
abdominal pain
headache ovarian hyperstimulation syndrome |
| gptkbp:usedFor |
female infertility
|
| gptkbp:bfsParent |
gptkb:MRK
|
| gptkbp:bfsLayer |
5
|